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Utilizing stem cells in the adult brain hold great promise for regenerative medicine. Harnessing 
ability of adult neural stem cells (NSCs) to generate new neurons or other types of brain cells may 
provide much needed therapies for patients suffering from brain injuries or neuro-degenerative 
diseases such as Parkinson’s, Scizophrenia, or Alzheimer’s disease. However, the treatments that 
involve stem cells are based in NSC transplantation and its efficiency is really low. 
The major barriers-to-progress in this area of research are immune-rejection of the implanted 
cells, faulty tumorogenic growth, but mainly, a faulty integration of the improper progeny. To avoid the 
problems that accompany NSC transplantation, we wanted to explore whether a new approach focused 
on “modulating” the brain’s own resident stem cells to produce the appropriate cells after brain damage 
was possible. In order to determine if “in situ” stem cell therapy was plausible, we first had to determine 
whether 1)	   Environment provides the right signals for the proper NSC function and generation of the 
appropriate progeny, 2) whether in vivo NCSs are capable to elaborate an appropriate response under 
different brain requirements, and 3) whether directed modulation of Neural Stem Cells function is 
possible.  
We found that using genetic alteration in only the neighboring ependymal cells has the profound 
impact of nearly eliminating new neuron production in the lateral ventricular neurogenic region.  
Secondly, we determined that cortical strokes that do not impact the neurogenic region induce 
production on TSP4+ astrocytes that migrate to the injury site to produce the scar that stops cortical 
bleeding.  Thirdly, we have identified a novel cholinergic circuit that resides in the neurogenic region, 
and that optogenetic stimulation or silencing of acetylcholine neurons can robustly up or down-regulate 
new neuron production. These three discoveries have met the required conditions for using intrinsic 
NSCs as therapy for brain regeneration and repair.  I am now extending this line of research to 
determine if this therapy is now a feasible technique for brain repair understanding how the local brain 
circuits are modified as the NSCs transition to an injury response and back to normal production 
following recovery.  Together these data suggest that therapies utilizing the bodies own intrinsic control 
mechanisms for NSC regulation may soon provide much needed avenues for future therapies that are 
unattainable with other methods. 
